Scientists aim to predict pancreatic cancer treatment success with new model
NCT ID NCT07326150
First seen Jan 10, 2026 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This observational study is collecting blood and tumor tissue from 70 pancreatic cancer patients to build a model that predicts how well a patient will respond to treatment. Researchers will analyze the samples using advanced techniques to find patterns linked to better outcomes. The goal is to create a tool that helps doctors choose the most effective therapy for each individual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER RESECTABLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Zhejiang, Hangzhou, 310022, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a tool that helps doctors predict which pancreatic cancer treatments will work best for each patient.
What could go wrong
This is a small, early observational study, not a treatment trial. The model may not prove accurate enough for real-world use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.